Sihuan Pharma’s Botox Beauty Bid Suffers Covid Wrinkle
The cardiovascular and cancer drug maker’s recent shift to the medical beauty business was doing well at first, but struggled last yearKey Takeaways:Sihuan Pharmaceutical’s recent move into the medical beauty…
Beauty Products Maker Imeik Makes Second Try at Hong Kong IPO
With ultra-high gross margins, the Chinese maker of wrinkle fillers makes second attempt at secondary listing in Hong Kong Key Takeaways: Started in 2004, Imeik is the largest provider of…
Giant Biogene IPO: A Collagen Queen, or Saggy-Skinned Stepsister?
The fast-growing skin-care products maker has filed for a Hong Kong listing that could value it at about $8.5 billion Key Takeaways: Giant Biogene has filed for a Hong Kong…